| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.49 | 0.08 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.08 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |